Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 71 articles:
HTML format
Text format



Single Articles


    March 2017
  1. BAUML J, Seiwert TY, Pfister DG, Worden F, et al
    Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study.
    J Clin Oncol. 2017 Mar 22:JCO2016701524. doi: 10.1200/JCO.2016.70.1524.
    PubMed     Text format     Abstract available


    February 2017
  2. NEKHLYUDOV L, Lacchetti C, Davis NB, Garvey TQ, et al
    Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society Guideline.
    J Clin Oncol. 2017 Feb 27:JCO2016718478. doi: 10.1200/JCO.2016.71.8478.
    PubMed     Text format     Abstract available


    December 2016
  3. RIBASSIN-MAJED L, Marguet S, Lee AW, Ng WT, et al
    What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.
    J Clin Oncol. 2016 Dec 5:JCO2016674119.
    PubMed     Text format     Abstract available


    September 2016
  4. CHOW LQ, Haddad R, Gupta S, Mahipal A, et al
    Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort.
    J Clin Oncol. 2016 Sep 19. pii: JCO681478.
    PubMed     Text format     Abstract available


    August 2016
  5. ACEVEDO JR, Fero KE, Wilson B, Sacco AG, et al
    Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer.
    J Clin Oncol. 2016 Aug 22. pii: JCO684563.
    PubMed     Text format     Abstract available


  6. DIVI V, Chen MM, Nussenbaum B, Rhoads KF, et al
    Lymph Node Count From Neck Dissection Predicts Mortality in Head and Neck Cancer.
    J Clin Oncol. 2016 Aug 1. pii: JCO673863.
    PubMed     Text format     Abstract available


    May 2016
  7. LI J, Qin S, Xu J, Xiong J, et al
    Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.
    J Clin Oncol. 2016;34:1448-54.
    PubMed     Text format     Abstract available


    April 2016
  8. WIRTH LJ
    Cetuximab in Human Papillomavirus-Positive Oropharynx Carcinoma.
    J Clin Oncol. 2016;34:1289-91.
    PubMed     Text format    


  9. SABA NF, Wong SJ
    Dual Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Inhibition in Squamous Cell Carcinoma of the Head and Neck; Is the Jury Still Out?
    J Clin Oncol. 2016 Apr 11. pii: JCO669085.
    PubMed     Text format    


  10. CARMONA R, Zakeri K, Green G, Hwang L, et al
    Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events.
    J Clin Oncol. 2016;34:1270-7.
    PubMed     Text format     Abstract available


  11. PATEL S, Ragab O, Demanes DJ, Chen AM, et al
    Brachytherapy: Where Has It Gone...Again?
    J Clin Oncol. 2016;34:1155.
    PubMed     Text format    


  12. RINGASH J
    Reply to N. Osazuwa-Peters et al.
    J Clin Oncol. 2016;34:1152.
    PubMed     Text format    


    March 2016
  13. KIM S
    Head and Neck Radiation Oncology: Is Busier Better?
    J Clin Oncol. 2016;34:653-4.
    PubMed     Text format    


    February 2016
  14. LOPES LF, Macedo CR, Aguiar Sdos S, Barreto JH, et al
    Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
    J Clin Oncol. 2016;34:603-10.
    PubMed     Text format     Abstract available


  15. HECHT JR, Bang YJ, Qin SK, Chung HC, et al
    Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial.
    J Clin Oncol. 2016;34:443-51.
    PubMed     Text format     Abstract available


  16. KHOT A, Love C, Garg MK, Haigentz M Jr, et al
    Long-Term Disease Control in a Patient With Recurrent Bone-Only Oligometastatic Nasopharyngeal Carcinoma.
    J Clin Oncol. 2016;34:e25-6.
    PubMed     Text format    


    January 2016
  17. THEKKEKARA R, Udayagiri VS, Patel U, Goldberg D, et al
    Depression and smoking patterns among head and neck cancer patients in an inner city minority population.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  18. MCQUESTION M, Sampson L, Le LW, Jones JM, et al
    Partner's survivorship care needs: Multivariable analysis in head and neck cancer patients.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  19. FELIX C, Hsu S
    Patient- versus physician-reported toxicities among survivors of head and neck cancer after chemoradiation: Prospective evaluation of screening methodologies.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  20. SHINN EH, Garden AS, Patrick K, Shete S, et al
    Identifying dehydration risk in head and neck cancer patients undergoing radiation therapy using remote, sensor-based monitoring: A randomized controlled trial.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  21. BAYOUMI Y, Senosy MA, Elawadi AA, AlHussain H, et al
    Patterns of failure and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation therapy in Saudi Arabia.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  22. BODMANN J, Koyfman SA, Nwizu TI, Joshi NP, et al
    Measuring impact of survivorship care plans on head and neck cancer patients.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  23. OSAZUWA-PETERS N, Adjei Boakye E, Walker RJ, Varvares MA, et al
    Suicide: A Major Threat to Head and Neck Cancer Survivorship.
    J Clin Oncol. 2016 Jan 19. pii: JCO654673.
    PubMed     Text format    


  24. BOERO IJ, Paravati AJ, Xu B, Cohen EE, et al
    Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy.
    J Clin Oncol. 2016 Jan 4. pii: JCO639898.
    PubMed     Text format     Abstract available


    December 2015
  25. ROSENTHAL DI, Harari PM, Giralt J, Bell D, et al
    Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Witho
    J Clin Oncol. 2015 Dec 28. pii: JCO625970.
    PubMed     Text format     Abstract available


  26. JANJIGIAN YY
    Lapatinib in Gastric Cancer: What Is the LOGiCal Next Step?
    J Clin Oncol. 2015 Dec 23. pii: JCO642892.
    PubMed     Text format    


  27. MAGRINI SM, Buglione M, Corvo R, Pirtoli L, et al
    Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial.
    J Clin Oncol. 2015 Dec 7. pii: JCO631671.
    PubMed     Text format     Abstract available


  28. HUSAIN ZA, Burtness BA, Decker RH
    Cisplatin Versus Cetuximab With Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
    J Clin Oncol. 2015 Dec 7. pii: JCO647586.
    PubMed     Text format    


    November 2015
  29. MURPHY CT, Galloway TJ, Handorf EA, Egleston BL, et al
    Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.
    J Clin Oncol. 2015 Nov 30. pii: JCO615906.
    PubMed     Text format     Abstract available


  30. MURPHY C, Schwalb H, Berlangieri S, Eek R, et al
    Intraluminal Superior Vena Cava Metastasis in a Patient With Poorly Differentiated Thyroid Carcinoma.
    J Clin Oncol. 2015;33:e119-21.
    PubMed     Text format    


  31. HARRINGTON K, Temam S, Mehanna H, D'Cruz A, et al
    Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled
    J Clin Oncol. 2015 Nov 2. pii: JCO.2015.61.4370.
    PubMed     Text format     Abstract available


  32. TURCOTTE LM, Whitton JA, Friedman DL, Hammond S, et al
    Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
    J Clin Oncol. 2015;33:3568-75.
    PubMed     Text format     Abstract available


    October 2015
  33. GALLOWAY TJ, Ridge JA
    Management of Squamous Cancer Metastatic to Cervical Nodes With an Unknown Primary Site.
    J Clin Oncol. 2015;33:3328-37.
    PubMed     Text format     Abstract available


  34. DILLON MT, Harrington KJ
    Human Papillomavirus-Negative Pharyngeal Cancer.
    J Clin Oncol. 2015;33:3251-61.
    PubMed     Text format     Abstract available


  35. BHATIA A, Burtness B
    Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials.
    J Clin Oncol. 2015;33:3243-50.
    PubMed     Text format     Abstract available


  36. BRUCE JP, Yip K, Bratman SV, Ito E, et al
    Nasopharyngeal Cancer: Molecular Landscape.
    J Clin Oncol. 2015;33:3346-55.
    PubMed     Text format     Abstract available


  37. HOLSINGER FC, Ferris RL
    Transoral Endoscopic Head and Neck Surgery and Its Role Within the Multidisciplinary Treatment Paradigm of Oropharynx Cancer: Robotics, Lasers, and Clinical Trials.
    J Clin Oncol. 2015;33:3285-92.
    PubMed     Text format     Abstract available


  38. CHINN SB, Myers JN
    Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions.
    J Clin Oncol. 2015;33:3269-76.
    PubMed     Text format     Abstract available


  39. HUANG SH, Xu W, Waldron J, Hope AJ, et al
    Reply to J.J. Beitler et al.
    J Clin Oncol. 2015;33:3218-9.
    PubMed     Text format    


  40. BEITLER JJ, LeCraw Mikell J, Switchenko J
    Human Papillomavirus-Related Oropharyngeal Cancer: Agree With a New Staging System, but the Devil Is in the Details.
    J Clin Oncol. 2015;33:3217-8.
    PubMed     Text format    


    September 2015
  41. BORGET I, Bonastre J, Catargi B, Deandreis D, et al
    Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial.
    J Clin Oncol. 2015;33:2885-92.
    PubMed     Text format     Abstract available


  42. LEE AW, Ma BB, Ng WT, Chan AT, et al
    Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective.
    J Clin Oncol. 2015 Sep 8. pii: JCO.2015.60.9347.
    PubMed     Text format     Abstract available


  43. GREGOIRE V, Langendijk JA, Nuyts S
    Advances in Radiotherapy for Head and Neck Cancer.
    J Clin Oncol. 2015 Sep 8. pii: JCO.2015.61.2994.
    PubMed     Text format     Abstract available


  44. HAYES DN, Van Waes C, Seiwert TY
    Genetic Landscape of Human Papillomavirus-Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors.
    J Clin Oncol. 2015 Sep 8. pii: JCO.2015.62.1086.
    PubMed     Text format     Abstract available


  45. PORCEDDU SV, Veness MJ, Guminski A
    Nonmelanoma Cutaneous Head and Neck Cancer and Merkel Cell Carcinoma: Current Concepts, Advances, and Controversies.
    J Clin Oncol. 2015 Sep 8. pii: JCO.2014.60.7333.
    PubMed     Text format     Abstract available


  46. SACCO AG, Cohen EE
    Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
    J Clin Oncol. 2015 Sep 8. pii: JCO.2015.62.0963.
    PubMed     Text format     Abstract available


  47. FORASTIERE AA, Weber RS, Trotti A
    Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes.
    J Clin Oncol. 2015 Sep 8. pii: JCO.2015.61.2978.
    PubMed     Text format     Abstract available


  48. GILLISON ML, Chaturvedi AK, Anderson WF, Fakhry C, et al
    Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.
    J Clin Oncol. 2015 Sep 8. pii: JCO.2015.61.6995.
    PubMed     Text format     Abstract available


  49. RINGASH J
    Survivorship and Quality of Life in Head and Neck Cancer.
    J Clin Oncol. 2015 Sep 8. pii: JCO.2015.61.4115.
    PubMed     Text format     Abstract available


  50. MURPHY BA, Deng J
    Advances in Supportive Care for Late Effects of Head and Neck Cancer.
    J Clin Oncol. 2015 Sep 8. pii: JCO.2015.61.3836.
    PubMed     Text format     Abstract available


  51. RISCHIN D, Ferris RL, Le QT
    Overview of Advances in Head and Neck Cancer.
    J Clin Oncol. 2015 Sep 8. pii: JCO.2015.63.6761.
    PubMed     Text format    


  52. FERRIS RL
    Immunology and Immunotherapy of Head and Neck Cancer.
    J Clin Oncol. 2015 Sep 8. pii: JCO.2015.61.1509.
    PubMed     Text format     Abstract available


    August 2015
  53. PEGUERO J, Khanfar A, Mannem S, Willis M, et al
    Impending Carotid Blowout Syndrome.
    J Clin Oncol. 2015;33:e97-8.
    PubMed     Text format    


  54. BAL C, Ballal S
    Is There Any True Association Between BRAF V600E Mutation and Recurrence, Particularly in Low-Risk, Papillary Thyroid Cancer?
    J Clin Oncol. 2015;33:2481.
    PubMed     Text format    


  55. XING M
    BRAF Mutation and Thyroid Cancer Recurrence.
    J Clin Oncol. 2015;33:2482-3.
    PubMed     Text format    


  56. XING M
    Reply to C. Bal et al.
    J Clin Oncol. 2015;33:2483-4.
    PubMed     Text format    


  57. YARCHOAN M, LiVolsi VA, Brose MS
    Reply to C. Bal et al and M. Xing.
    J Clin Oncol. 2015;33:2483.
    PubMed     Text format    


    July 2015
  58. MARKAR S, Gronnier C, Duhamel A, Pasquer A, et al
    Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option?
    J Clin Oncol. 2015 Jul 20. pii: JCO.2014.59.9092.
    PubMed     Text format     Abstract available


  59. ADAM MA, Pura J, Goffredo P, Dinan MA, et al
    Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.
    J Clin Oncol. 2015;33:2370-5.
    PubMed     Text format     Abstract available


    June 2015
  60. SMYTH EC, Cunningham D
    Epirubicin, Cisplatin, and Capecitabine Versus Fluorouracil, Leucovorin, and Irinotecan for Esophagogastric Cancer: The Original and the Rest.
    J Clin Oncol. 2015 Jun 15. pii: JCO.2014.59.7088.
    PubMed     Text format    


  61. STARR JS, Attia S, Joseph RW, Menke D, et al
    Follicular Dendritic Cell Sarcoma Presenting As a Thyroid Mass.
    J Clin Oncol. 2015;33:e74-6.
    PubMed     Text format    


    May 2015
  62. O'SULLIVAN B, Adelstein DL, Huang SH, Koyfman SA, et al
    First Site of Failure Analysis Incompletely Addresses Issues of Late and Unexpected Metastases in p16-Positive Oropharyngeal Cancer.
    J Clin Oncol. 2015;33:1707-8.
    PubMed     Text format    


  63. PFISTER DG, Baxi SS, Dunn LA, Fury MG, et al
    Reply to B. O'Sullivan et Al.
    J Clin Oncol. 2015;33:1710.
    PubMed     Text format    


  64. FAKHRY C, Zhang Q, Nguyen-Tan PF, Rosenthal D, et al
    Reply to B. O'Sullivan et Al.
    J Clin Oncol. 2015;33:1708-9.
    PubMed     Text format    


    April 2015
  65. ADKINS D, Ley J, Wildes TM, Michel L, et al
    RTOG 0522: huge Investment in patients and resources and no benefit with addition of cetuximab to radiotherapy--why did this occur?
    J Clin Oncol. 2015;33:1223-4.
    PubMed     Text format    


  66. AXELROD RS, Sherman E, Garden A, Nguyen-Tan PF, et al
    Reply to D. Adkins et al.
    J Clin Oncol. 2015;33:1224-5.
    PubMed     Text format    


  67. PSYRRI A, Economopoulou P, Dafni U
    Reply to D. Adkins et al.
    J Clin Oncol. 2015;33:1225-6.
    PubMed     Text format    


    March 2015
  68. TURKINGTON RC, Parkes E, Kennedy RD, Eatock MM, et al
    Clinical tumor staging of adenocarcinoma of the esophagus and esophagogastric junction.
    J Clin Oncol. 2015;33:1088.
    PubMed     Text format    


  69. DAVIES AR, Gossage JA, Zylstra JL, Mattsson F, et al
    Reply to R.C. Turkington et al.
    J Clin Oncol. 2015;33:1089-90.
    PubMed     Text format    


  70. COHEN EE, Kocherginsky M, Karrison T, Seiwert TY, et al
    Reply to s. Chakraborty et al.
    J Clin Oncol. 2015;33:968.
    PubMed     Text format    


  71. BRIZEL DM
    Different strokes for different folks: new paradigms for staging oropharynx cancer.
    J Clin Oncol. 2015;33:817-8.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: